BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16673060)

  • 1. Religious belief as a coping strategy: an explorative trial in patients irradiated for head-and-neck cancer.
    Becker G; Momm F; Xander C; Bartelt S; Zander-Heinz A; Budischewski K; Domin C; Henke M; Adamietz IA; Frommhold H
    Strahlenther Onkol; 2006 May; 182(5):270-6. PubMed ID: 16673060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychological coping style versus disease extent, tumour treatment and quality of life in successfully treated head and neck squamous cell carcinoma patients.
    Aarstad AK; Aarstad HJ; Bru E; Olofsson J
    Clin Otolaryngol; 2005 Dec; 30(6):530-8. PubMed ID: 16402979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term quality of life of patients with head and neck cancer.
    de Graeff A; de Leeuw JR; Ros WJ; Hordijk GJ; Blijham GH; Winnubst JA
    Laryngoscope; 2000 Jan; 110(1):98-106. PubMed ID: 10646723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in elderly patients with head and neck cancer one year after diagnosis.
    Derks W; de Leeuw RJ; Hordijk GJ; Winnubst JA
    Head Neck; 2004 Dec; 26(12):1045-52. PubMed ID: 15459917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personality and choice of coping predict quality of life in head and neck cancer patients during follow-up.
    Aarstad AK; Aarstad HJ; Olofsson J
    Acta Oncol; 2008; 47(5):879-90. PubMed ID: 18568484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.
    Duncan GG; Epstein JB; Tu D; El Sayed S; Bezjak A; Ottaway J; Pater J;
    Head Neck; 2005 May; 27(5):421-8. PubMed ID: 15782422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective studies on mental status and quality of life in patients with head and neck cancer treated by radiation.
    Kohda R; Otsubo T; Kuwakado Y; Tanaka K; Kitahara T; Yoshimura K; Mimura M
    Psychooncology; 2005 Apr; 14(4):331-6. PubMed ID: 15655808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deterioration in quality of life and depressive symptoms during radiation therapy for head and neck cancer.
    Kelly C; Paleri V; Downs C; Shah R
    Otolaryngol Head Neck Surg; 2007 Jan; 136(1):108-11. PubMed ID: 17210344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
    Graff P; Lapeyre M; Desandes E; Ortholan C; Bensadoun RJ; Alfonsi M; Maingon P; Giraud P; Bourhis J; Marchesi V; Mège A; Peiffert D
    Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1309-17. PubMed ID: 17289292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
    Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
    Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck.
    Lassen P; Eriksen JG; Hamilton-Dutoit S; Tramm T; Alsner J; Overgaard J
    J Clin Oncol; 2009 Apr; 27(12):1992-8. PubMed ID: 19289615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of comorbidity on quality of life during radiotherapy in head and neck cancer.
    Oozeer NB; Benbow J; Downs C; Kelly C; Welch A; Paleri V
    Otolaryngol Head Neck Surg; 2008 Aug; 139(2):268-72. PubMed ID: 18656727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy.
    Langendijk JA; Doornaert P; Verdonck-de Leeuw IM; Leemans CR; Aaronson NK; Slotman BJ
    J Clin Oncol; 2008 Aug; 26(22):3770-6. PubMed ID: 18669465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of acute grade 4 swallowing toxicity in patients with stages III and IV squamous carcinoma of the head and neck treated with radiotherapy alone.
    Poulsen MG; Riddle B; Keller J; Porceddu SV; Tripcony L
    Radiother Oncol; 2008 May; 87(2):253-9. PubMed ID: 18410976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment quality of life predicts for locoregional control in head and neck cancer patients: a radiation therapy oncology group analysis.
    Siddiqui F; Pajak TF; Watkins-Bruner D; Konski AA; Coyne JC; Gwede CK; Garden AS; Spencer SA; Jones C; Movsas B
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):353-60. PubMed ID: 17889449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prosthodontic rehabilitation of oral function in head-neck cancer patients with dental implants placed simultaneously during ablative tumour surgery: an assessment of treatment outcomes and quality of life.
    Schoen PJ; Raghoebar GM; Bouma J; Reintsema H; Burlage FR; Roodenburg JL; Vissink A
    Int J Oral Maxillofac Surg; 2008 Jan; 37(1):8-16. PubMed ID: 17766084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia.
    Ringash J; Warde P; Lockwood G; O'Sullivan B; Waldron J; Cummings B
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1403-7. PubMed ID: 15817343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between saliva production and quality of life measurements in head and neck cancer patients treated with intensity-modulated radiotherapy.
    Scrimger R; Kanji A; Parliament M; Warkentin H; Field C; Jha N; Hanson J
    Am J Clin Oncol; 2007 Jun; 30(3):271-7. PubMed ID: 17551304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice].
    Horiot JC; Bontemps P; Begg AC; Le Fur R; Van den Bogaert W; Bolla M; N'Guyen T; Van den Weijngaert D; Bernier J; Lusinchi A; Stuschke D; Lopez Torrecilla D; Jancar B; Collette L; Van Glabbeke M; Pierart M
    Bull Cancer Radiother; 1996; 83(4):314-20. PubMed ID: 9081333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.